Literature DB >> 24992629

Neoadjuvant treatment with dabrafenib of unresectable localizations from occult melanoma.

Marco Rastrelli1, Jacopo Pigozzo, Antonio di Maggio, Anna L Tosi, Vanna Chiarion Sileni, Carlo R Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24992629     DOI： 10.1097/CMR.0000000000000083

Source DB:  PubMed          Journal:  Melanoma Res        ISSN： 0960-8931            Impact factor:   3.599


× No keyword cloud information.
  5 in total

Review 1.  Adjuvant treatment for stage III melanoma in the era of targeted medicine and immunotherapy.

Authors:  Eytan Ben-Ami; Jacob Schachter
Journal:  Melanoma Manag       Date:  2016-05-25

2.  Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma.

Authors:  Zeynep Eroglu; Jennifer Eatrides; Syeda Mahrukh Hussnain Naqvi; Youngchul Kim; Jeani Rich; Nalan Akgul Babacan; Andrew S Brohl; Joseph Markowitz; Amod Sarnaik; Jonathan Zager; Nikhil I Khushalani; Vernon K Sondak; Jane Messina
Journal:  Pigment Cell Melanoma Res       Date:  2019-09-12       Impact factor: 4.693

Review 3.  Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.

Authors:  Kierstin Utter; Chloe Goldman; Sarah A Weiss; Richard L Shapiro; Russell S Berman; Melissa Ann Wilson; Anna C Pavlick; Iman Osman
Journal:  Oncology       Date:  2017-07-27       Impact factor: 2.935

4.  Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma.

Authors:  Renáta Váraljai; Susanne Horn; Antje Sucker; Daniela Piercianek; Verena Schmitt; Alexander Carpinteiro; Katrin Anne Becker; Julia Reifenberger; Alexander Roesch; Joerg Felsberg; Guido Reifenberger; Ulrich Sure; Dirk Schadendorf; Iris Helfrich
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

5.  Preoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma.

Authors:  Marloes Faut; Mathilde Jalving; Gilles F Diercks; Geke A Hospers; Barbara L van Leeuwen; Lukas B Been
Journal:  Melanoma Manag       Date:  2018-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.